CoChat

Pro-BDNF–induced synaptic depression and retraction at developing neuromuscular synapses

Open access
Yang, Feng, Je, Hyun-Soo, Ji, Yuanyuan, Nagappan, Guhan, Hempstead, Barbara, Lu, Bai · 2009 · Journal of Cell Biology

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Postsynaptic cells generate positive and negative signals that retrogradely modulate presynaptic function. At developing neuromuscular synapses, prolonged stimulation of muscle cells induces sustained synaptic depression. We provide evidence that pro–brain-derived neurotrophic factor (BDNF) is a negative retrograde signal that can be converted into a positive signal by metalloproteases at the synaptic junctions. Application of pro-BDNF induces a dramatic decrease in synaptic efficacy followed by a retraction of presynaptic terminals, and these effects are mediated by presynaptic pan-neurotrophin receptor p75 (p75NTR), the pro-BDNF receptor. A brief stimulation of myocytes expressing cleavable or uncleavable pro-BDNF elicits synaptic potentiation or depression, respectively. Extracellular application of metalloprotease inhibitors, which inhibits the cleavage of endogenous pro-BDNF, facilitates the muscle stimulation–induced synaptic depression. Inhibition of presynaptic p75NTR or postsynaptic BDNF expression also blocks the activity-dependent synaptic depression and retraction. These results support a model in which postsynaptic secretion of a single molecule, pro-BDNF, may stabilize or eliminate presynaptic terminals depending on its proteolytic conversion at the synapses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.200811147

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Synaptic depression induced by pro-BDNF application. Data from individual synapses were averaged from 10 min of recording before and 30 min after pro-BDNF treatment. All data are presented as mean ± SEM. The number associated with each bar in the graphs represents the number of cells analyzed. The asterisks indicate a significantly higher result than that for the respective “before treatment” group by a t test (*, P < 0.05). (A) Sample recordings of SSCs from a neuromuscular synapse before and after the application of cleavage-resistant pro-BDNF. The top recording shows a rapid and persistent decrease in SSC frequency after pro-BDNF application, whereas the bottom recording demonstrates the recovery of synaptic efficacy after washout of pro-BDNF from the culture. (B) Time course of pro-BDNF–induced synaptic depression. Each point represents the mean frequency of SSCs (every 2 min) for 10 min before and 40 min after pro-BDNF treatment. After washout of pro-BDNF from culture within 5–10 min (closed square), the synaptic efficacy was recovered. However, after pro-BDNF washout after 10 min (closed circle), the synaptic depression persisted. The numbers in parentheses indicate the number of synapses recorded. (C) Effect of pro-BDNF on SSC amplitude. (D) Effect of pro-BDNF on rise time and decay time of SSCs. (E) Superimposed traces of ESCs before and 30 min after pro-BDNF treatment. (F) Amplitude and delay of onset of ESCs before and after pro-BDNF treatment.
Figure 1. Synaptic depression induced by pro-BDNF application. Data from individual synapses were averaged from 10 min of recording before and 30 min after pro-BDNF treatment. All data are presented as mean ± SEM. The number associated with each bar in the graphs represents the number of cells analyzed. The asterisks indicate a significantly higher result than that for the respective “before treatment” group by a t test (*, P < 0.05). (A) Sample recordings of SSCs from a neuromuscular synapse before and after the application of cleavage-resistant pro-BDNF. The top recording shows a rapid and persistent decrease in SSC frequency after pro-BDNF application, whereas the bottom recording demonstrates the recovery of synaptic efficacy after washout of pro-BDNF from the culture. (B) Time course of pro-BDNF–induced synaptic depression. Each point represents the mean frequency of SSCs (every 2 min) for 10 min before and 40 min after pro-BDNF treatment. After washout of pro-BDNF from culture within 5–10 min (closed square), the synaptic efficacy was recovered. However, after pro-BDNF washout after 10 min (closed circle), the synaptic depression persisted. The numbers in parentheses indicate the number of synapses recorded. (C) Effect of pro-BDNF on SSC amplitude. (D) Effect of pro-BDNF on rise time and decay time of SSCs. (E) Superimposed traces of ESCs before and 30 min after pro-BDNF treatment. (F) Amplitude and delay of onset of ESCs before and after pro-BDNF treatment.CC BY-NC-SA · PubMed Central
Figure 2. Pro-BDNF–mediated synaptic depression is mediated by presynaptic p75NTR. (A) Down-regulation of p75NTR by siRNA. p75NTR-specific siRNA and scrambled (Scrm.) analogues were introduced into the developing Xenopus by embryo injection. Neural tubes were dissected, and proteins were extracted. Western blots were performed using anti-p75NTR–specific antibody together with an antitubulin antibody for loading controls. Note a reduction of p75NTR expression in p75NTR siRNA–injected but not in uninjected (control [Ctl.]) or scrambled siRNA–injected embryos (left). Quantitative analysis of p75NTR expression in four independent experiments (right) is shown. The number in the bar indicates the number of Western blots performed. (B) Attenuation of pro-BDNF effect on SSCs by presynaptic expression of siRNA and its rescue by coexpression with rat p75NTR. p75NTR siRNA was expressed in presynaptic neurons (N+), postsynaptic myocytes (M+), or not at all (N−). Scrambled p75NTR siRNA was used as a control. In the last set of experiments, coexpression of p75NTR siRNA with rat p75NTR mRNA reversed the effect of p75NTR siRNA. (C) Effect of p75NTR siRNA on pro-BDNF–induced depression of ESCs. Amplitude (left) and delay of onset (right) of ESCs at control synapses (N−) and synapses expressing p75NTR siRNA (N+) are presented. The numbers in the bars indicate the number of synapses recorded. (A–C) Error bars represent SEM. *, P < 0.05.
Figure 2. Pro-BDNF–mediated synaptic depression is mediated by presynaptic p75NTR. (A) Down-regulation of p75NTR by siRNA. p75NTR-specific siRNA and scrambled (Scrm.) analogues were introduced into the developing Xenopus by embryo injection. Neural tubes were dissected, and proteins were extracted. Western blots were performed using anti-p75NTR–specific antibody together with an antitubulin antibody for loading controls. Note a reduction of p75NTR expression in p75NTR siRNA–injected but not in uninjected (control [Ctl.]) or scrambled siRNA–injected embryos (left). Quantitative analysis of p75NTR expression in four independent experiments (right) is shown. The number in the bar indicates the number of Western blots performed. (B) Attenuation of pro-BDNF effect on SSCs by presynaptic expression of siRNA and its rescue by coexpression with rat p75NTR. p75NTR siRNA was expressed in presynaptic neurons (N+), postsynaptic myocytes (M+), or not at all (N−). Scrambled p75NTR siRNA was used as a control. In the last set of experiments, coexpression of p75NTR siRNA with rat p75NTR mRNA reversed the effect of p75NTR siRNA. (C) Effect of p75NTR siRNA on pro-BDNF–induced depression of ESCs. Amplitude (left) and delay of onset (right) of ESCs at control synapses (N−) and synapses expressing p75NTR siRNA (N+) are presented. The numbers in the bars indicate the number of synapses recorded. (A–C) Error bars represent SEM. *, P < 0.05.CC BY-NC-SA · PubMed Central
Figure 3. Pro-BDNF–induced synaptic retraction mediated by presynaptic p75NTR. (A) Time-lapse images showing the retraction of a nerve terminal from its target myocyte (M) after pro-BDNF treatment. The spinal neuron (N) is labeled with GFP (green), and AChRs on the postsynaptic membrane are labeled with rhodamine-conjugated α-BTX (red). Pro-BDNF was applied at time 0. Enlarged images of an area within the white box are shown at the left and were captured at the indicated times (shown in minutes) after pro-BDNF application. The GFP-labeled axonal terminal (yellow arrows) clearly occupied the synaptic site (colocalized with AChRs; yellow) before treatment but progressively withdrew from the junction after pro-BDNF treatment. Note that the cell body of the neuron remained healthy even after 2 h. (B) Time-lapse images showing that pro-BDNF failed to induce retraction of an axon of a neuron expressing p75NTR siRNA. Note that upon application of pro-BDNF, the terminals either did not retract (white arrows) or continued to extend further (white arrowheads). The inset is magnified to show more detailed images of the synapses. (C) Time course of synaptic retraction under different conditions. The number of experiments performed in each condition is indicated in parentheses. Error bars represent SEM. Scrm., scrambled. Bars, 10 µm.
Figure 3. Pro-BDNF–induced synaptic retraction mediated by presynaptic p75NTR. (A) Time-lapse images showing the retraction of a nerve terminal from its target myocyte (M) after pro-BDNF treatment. The spinal neuron (N) is labeled with GFP (green), and AChRs on the postsynaptic membrane are labeled with rhodamine-conjugated α-BTX (red). Pro-BDNF was applied at time 0. Enlarged images of an area within the white box are shown at the left and were captured at the indicated times (shown in minutes) after pro-BDNF application. The GFP-labeled axonal terminal (yellow arrows) clearly occupied the synaptic site (colocalized with AChRs; yellow) before treatment but progressively withdrew from the junction after pro-BDNF treatment. Note that the cell body of the neuron remained healthy even after 2 h. (B) Time-lapse images showing that pro-BDNF failed to induce retraction of an axon of a neuron expressing p75NTR siRNA. Note that upon application of pro-BDNF, the terminals either did not retract (white arrows) or continued to extend further (white arrowheads). The inset is magnified to show more detailed images of the synapses. (C) Time course of synaptic retraction under different conditions. The number of experiments performed in each condition is indicated in parentheses. Error bars represent SEM. Scrm., scrambled. Bars, 10 µm.CC BY-NC-SA · PubMed Central
Figure 4. Simultaneous recordings of pro-BDNF–induced synaptic depression and imaging of terminal retraction. (top) Time-lapse images showing progressive retraction of a nerve terminal from a myocyte after pro-BDNF treatment. The dotted circle indicates the myocytes recorded; the dotted line indicates the recording pipette; the arrows indicate the axon terminal. (bottom) Simultaneous recording of SSC recording. The recording shows a rapid and persistent decrease in SSC frequency after pro-BDNF application. Note that synaptic depression precedes axonal retraction from its target myocyte. n = 4 independent experiments. Bar, 10 µm.
Figure 4. Simultaneous recordings of pro-BDNF–induced synaptic depression and imaging of terminal retraction. (top) Time-lapse images showing progressive retraction of a nerve terminal from a myocyte after pro-BDNF treatment. The dotted circle indicates the myocytes recorded; the dotted line indicates the recording pipette; the arrows indicate the axon terminal. (bottom) Simultaneous recording of SSC recording. The recording shows a rapid and persistent decrease in SSC frequency after pro-BDNF application. Note that synaptic depression precedes axonal retraction from its target myocyte. n = 4 independent experiments. Bar, 10 µm.CC BY-NC-SA · PubMed Central
Figure 5. Synaptic modulation elicited by stimulation of myocytes expressing cleavable and cleavage-resistant pro-BDNF. (A) Superimposed differential interference contrast and GFP fluorescence image showing a motor neuron (N) innervating a myocyte (M) expressing cleavage-resistant pro-BDNF (green). The dashed lines indicate the recording pipette. (B and C) Examples (left) and summary (right) of SSC recordings before and after stimulation of postsynaptic myocytes expressing cleavable (Clev.; B) and cleavage-resistant (uncleavable [Unclev.]; C) AA–pro-BDNF. Repetitive depolarization was applied to the postsynaptic myocytes through a whole-cell recording pipette (1 Hz for 30 s) under the current-clamp condition (Stim.). Note that at synapses expressing cleavable pro-BDNF, SSC frequency increased after postsynaptic depolarization. In contrast, at synapses expressing cleavage-resistant pro-BDNF, SSC frequency decreased after postsynaptic depolarization. The numbers in parentheses indicate the number of synapses recorded. (D) Quantitative analysis of amplitude (left), rise time (middle), and decay time (right) of SSCs before and after stimulation (Stim.) of postsynaptic myocytes expressing cleavable and cleavage-resistant pro-BDNF. The numbers in the bars indicate the number of synapses recorded. *, P < 0.05. (B–D) Error bars represent SEM. Bar, 10 µm.
Figure 5. Synaptic modulation elicited by stimulation of myocytes expressing cleavable and cleavage-resistant pro-BDNF. (A) Superimposed differential interference contrast and GFP fluorescence image showing a motor neuron (N) innervating a myocyte (M) expressing cleavage-resistant pro-BDNF (green). The dashed lines indicate the recording pipette. (B and C) Examples (left) and summary (right) of SSC recordings before and after stimulation of postsynaptic myocytes expressing cleavable (Clev.; B) and cleavage-resistant (uncleavable [Unclev.]; C) AA–pro-BDNF. Repetitive depolarization was applied to the postsynaptic myocytes through a whole-cell recording pipette (1 Hz for 30 s) under the current-clamp condition (Stim.). Note that at synapses expressing cleavable pro-BDNF, SSC frequency increased after postsynaptic depolarization. In contrast, at synapses expressing cleavage-resistant pro-BDNF, SSC frequency decreased after postsynaptic depolarization. The numbers in parentheses indicate the number of synapses recorded. (D) Quantitative analysis of amplitude (left), rise time (middle), and decay time (right) of SSCs before and after stimulation (Stim.) of postsynaptic myocytes expressing cleavable and cleavage-resistant pro-BDNF. The numbers in the bars indicate the number of synapses recorded. *, P < 0.05. (B–D) Error bars represent SEM. Bar, 10 µm.CC BY-NC-SA · PubMed Central
Figure 6. Synaptic depression induced by postsynaptic secretion of endogenous pro-BDNF, which is processed by MMP3 and MMP9. (A, top) A schematic diagram showing a synapse in which a spherical myocyte (M) is innervated by single spinal neurons (N). The dashed lines indicate the recording pipette. (bottom) The experimental protocol is shown. After baseline recording (10 min), protease inhibitors were applied for 10 min. Repetitive depolarization was applied to the postsynaptic myocytes through a whole-cell recording pipette (1 Hz for 30 s) under current-clamp condition, and synaptic efficacy was monitored. (B) Quantitative analysis of depolarization-induced depression caused by treatment with protease inhibitors (In.). Note that treatment with protease inhibitors alone or stimulation alone did not alter SSC frequency, but stimulation in the presence of protease inhibitors markedly reduced synaptic efficacy. (C) Specific MMPs involved in depolarization-induced synaptic depression. 50 nM MMP3 inhibitor, 50 µM MMP9 inhibitor, or both were applied to the cultures for at least 10 min. Synaptic depression was induced by postsynaptic stimulation (stim.) as described in Fig. 4. Note that postsynaptic stimulation in the presence of both MMP3 and MMP9 inhibitors but not either one alone triggered synaptic depression. (B and C) The numbers in the bars indicate the number of synapses recorded. Error bars represent SEM. *, P < 0.05.
Figure 6. Synaptic depression induced by postsynaptic secretion of endogenous pro-BDNF, which is processed by MMP3 and MMP9. (A, top) A schematic diagram showing a synapse in which a spherical myocyte (M) is innervated by single spinal neurons (N). The dashed lines indicate the recording pipette. (bottom) The experimental protocol is shown. After baseline recording (10 min), protease inhibitors were applied for 10 min. Repetitive depolarization was applied to the postsynaptic myocytes through a whole-cell recording pipette (1 Hz for 30 s) under current-clamp condition, and synaptic efficacy was monitored. (B) Quantitative analysis of depolarization-induced depression caused by treatment with protease inhibitors (In.). Note that treatment with protease inhibitors alone or stimulation alone did not alter SSC frequency, but stimulation in the presence of protease inhibitors markedly reduced synaptic efficacy. (C) Specific MMPs involved in depolarization-induced synaptic depression. 50 nM MMP3 inhibitor, 50 µM MMP9 inhibitor, or both were applied to the cultures for at least 10 min. Synaptic depression was induced by postsynaptic stimulation (stim.) as described in Fig. 4. Note that postsynaptic stimulation in the presence of both MMP3 and MMP9 inhibitors but not either one alone triggered synaptic depression. (B and C) The numbers in the bars indicate the number of synapses recorded. Error bars represent SEM. *, P < 0.05.CC BY-NC-SA · PubMed Central
Figure 7. Synaptic depression induced by postsynaptic secretion of endogenous pro-BDNF, which activates presynaptic p75NTR. (A) Down-regulation of pro-BDNF by BDNF morpholino. Xenopus BDNF–specific morpholino (Morph.) and scrambled (Scrm.) analogues were introduced by embryo injection. Neural tubes were dissected, and proteins were extracted. Western blots were performed using anti-BDNF antibodies. The blot was reprobed with an antitubulin antibody for loading controls. Note a reduction of pro-BDNF expression in BDNF morpholino–injected but not in uninjected (control [Ctl.]) or scrambled morpholino–injected embryos (left). Quantitative analysis of pro-BDNF expression in four independent experiments (right) is shown. The numbers in the bars indicate the number of Western blots performed. (B) Effect of presynaptic (N+) or postsynaptic (M+) expression of BDNF morpholino on depolarization-induced depression. (C) Effect of presynaptic or postsynaptic expression of p75NTR siRNA on depolarization-induced depression. (B and C) The numbers in the bars indicate the number of synapses recorded. (A–C) Error bars represent SEM. *, P < 0.05. In., inhibitor; stim., stimulation.
Figure 7. Synaptic depression induced by postsynaptic secretion of endogenous pro-BDNF, which activates presynaptic p75NTR. (A) Down-regulation of pro-BDNF by BDNF morpholino. Xenopus BDNF–specific morpholino (Morph.) and scrambled (Scrm.) analogues were introduced by embryo injection. Neural tubes were dissected, and proteins were extracted. Western blots were performed using anti-BDNF antibodies. The blot was reprobed with an antitubulin antibody for loading controls. Note a reduction of pro-BDNF expression in BDNF morpholino–injected but not in uninjected (control [Ctl.]) or scrambled morpholino–injected embryos (left). Quantitative analysis of pro-BDNF expression in four independent experiments (right) is shown. The numbers in the bars indicate the number of Western blots performed. (B) Effect of presynaptic (N+) or postsynaptic (M+) expression of BDNF morpholino on depolarization-induced depression. (C) Effect of presynaptic or postsynaptic expression of p75NTR siRNA on depolarization-induced depression. (B and C) The numbers in the bars indicate the number of synapses recorded. (A–C) Error bars represent SEM. *, P < 0.05. In., inhibitor; stim., stimulation.CC BY-NC-SA · PubMed Central
Figure 8. Synaptic retraction induced by postsynaptic secretion of endogenous pro-BDNF. Nerve terminals were labeled by rhodamine-dextran (red). The expression of BDNF morpholino (morph.) is indicated by the green fluorescence. Repetitive depolarization was applied to the postsynaptic myocytes (M) through a whole-cell recording pipette (2 Hz for 2 min) under current-clamp condition, and the axon terminal was visualized by time-lapse microscopy. (A) Synaptic retraction induced by repetitive postsynaptic stimulation. The axon was filled with rhodamine-dextran to visualize the axon terminal. After 30 min, the axon terminal from a stimulated myocyte retracted (indicated by yellow arrows). (B and C) Effect of presynaptic (B) or postsynaptic (C) expression of BDNF morpholino on depolarization-induced synaptic retraction. Postsynaptic expression of BDNF morpholino in myocytes blocked synaptic retracted induced by repetitive postsynaptic stimulation (indicated by white arrows). However, presynaptic expression of BDNF morpholino in spinal neurons could not block the depolarization-induced synaptic retraction (indicated by yellow arrows). The insets are magnified to show more detailed images of the synapses. (A–C) The dotted circles indicate myocytes recorded with a patch electrode. Bars, 10 µm.
Figure 8. Synaptic retraction induced by postsynaptic secretion of endogenous pro-BDNF. Nerve terminals were labeled by rhodamine-dextran (red). The expression of BDNF morpholino (morph.) is indicated by the green fluorescence. Repetitive depolarization was applied to the postsynaptic myocytes (M) through a whole-cell recording pipette (2 Hz for 2 min) under current-clamp condition, and the axon terminal was visualized by time-lapse microscopy. (A) Synaptic retraction induced by repetitive postsynaptic stimulation. The axon was filled with rhodamine-dextran to visualize the axon terminal. After 30 min, the axon terminal from a stimulated myocyte retracted (indicated by yellow arrows). (B and C) Effect of presynaptic (B) or postsynaptic (C) expression of BDNF morpholino on depolarization-induced synaptic retraction. Postsynaptic expression of BDNF morpholino in myocytes blocked synaptic retracted induced by repetitive postsynaptic stimulation (indicated by white arrows). However, presynaptic expression of BDNF morpholino in spinal neurons could not block the depolarization-induced synaptic retraction (indicated by yellow arrows). The insets are magnified to show more detailed images of the synapses. (A–C) The dotted circles indicate myocytes recorded with a patch electrode. Bars, 10 µm.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 130

Metadata

Authors
Yang, F., Je, H.-S., Ji, Y., Nagappan, G., Hempstead, B., & Lu, B.
Affiliations
  • National Institutes of Health (US)
  • Section on Neural Development and Plasticity, National Institute of Child Health and Human Development 1 and 2
  • Cornell University (US)
Corresponding author
Lu, Bai
Venue
Journal of Cell Biology
Published
2009-05-18
Volume
185
Issue
4
Pages
727-741
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2091428840
Cited by
130
References
50
Citations by year
2026: 4 · 2025: 1 · 2024: 5 · 2022: 6 · 2021: 7 · 2020: 10 · 2019: 10 · 2018: 8 · 2017: 12 · 2016: 7 · 2015: 5 · 2014: 10 · 2013: 9 · 2012: 13
FWCI
4.97
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
National Institutes of Health
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
synaptic depression, p75 neurotrophin receptor, metalloprotease cleavage, retrograde signaling, presynaptic terminals, synaptic potentiation, muscle stimulation, activity-dependent synaptic plasticity
MeSH terms
Animals, Synaptic Transmission, Neuromuscular Junction, Protein Precursors, Synapses, Xenopus, Presynaptic Terminals, Brain-Derived Neurotrophic Factor, Receptor, Nerve Growth Factor, Muscle Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.